Am I looking at the proverbial needle in the haystack when looking at MSTR (are you in 100% disagreement with maybe a 1% sucess rate)?.......I'm more interested in the overall percentage of probable sucess regarding the dynamics of implementing an R/S and from what I've seen, it's no better than RG getting another 100 million of authorized dilutive stock (to now possibly R/S it?).........The bottom line remains mgmt. getting money to the bottom line IMO, particulary when talking about institutional buying. To me, it was pointless to do these roadshows with our price, our current bottom line performance, and USTPO uncertainty hanging over our heads.......Another idea for debate, how would you consider Crossflo being spun off as an IPO?........